AgenT is a pioneering brand dedicated to revolutionizing Alzheimer's detection. With a strong focus on early diagnosis, AgenT is developing a ground-breaking multiomics blood test that can detect this debilitating disease before irreversible symptoms occur. By combining Machine Learning with innovative biomarkers, AgenT's test can identify Alzheimer's patients up to 20 years in advance, when intervention and prevention are still possible.

Traditional diagnostic tools often fall short, as they only detect the disease when it's too late. AgenT aims to change that by using a routine blood draw for early detection, similar to cancer screenings. Their multiomics platform analyzes proteins and metabolites in blood plasma, while their breakthrough Machine Learning allows for a deeper understanding of the body's response to Alzheimer's.

With their cutting-edge blood test and new therapeutic targets, AgenT is empowering physicians and paving the way for a future where Alzheimer's prevention is within reach. Stay connected with AgenT to receive the latest updates on clinical trials, publications, and more